Advisor Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Advisor Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$2K	Hold	141	–	–	﹤0.01%	4986
2019 Q3	$1K	Sell	141 -122	-46%	-$1.19K	﹤0.01%	5126
2019 Q2	$3K	Sell	263 -51	-16%	-$571	﹤0.01%	4863
2019 Q1	$3K	Buy	314 +61	+24%	+$681	﹤0.01%	4847
2018 Q4	$2K	Sell	253 -484	-66%	-$5.55K	﹤0.01%	4819
2018 Q3	$11K	Buy	737 +533	+261%	+$8.43K	﹤0.01%	4234
2018 Q2	$3K	Hold	204	–	–	﹤0.01%	4549
2018 Q1	$2K	Sell	204 -12	-6%	-$150	﹤0.01%	4690
2017 Q4	$3K	Sell	216 -99	-31%	-$1.29K	﹤0.01%	4571
2017 Q3	$4K	Buy	315 +112	+55%	+$1.54K	﹤0.01%	4353
2017 Q2	$3K	Buy	203 +90	+80%	+$1.31K	﹤0.01%	4411
2017 Q1	$1K	Buy	113 +21	+23%	+$287	﹤0.01%	4535
2016 Q4	$1K	Hold	92	–	–	﹤0.01%	4361
2016 Q3	$1K	Buy	+92	New	+$1.08K	﹤0.01%	4308

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisor Group's IRWD Position: Q4 2019 in Review

Advisor Group held its Ironwood Pharmaceuticals (IRWD) position steady in Q4 2019 at 141 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #4986.

Advisor Group first reported a position in IRWD in Q3 2016 and has held it in 14 quarters since. The position peaked at $11K in Q3 2018. 195 funds tracked by Wall St. Rank hold IRWD as of Q4 2019.

Advisor Group held 141 shares of Ironwood Pharmaceuticals worth $2K as of Q4 2019.
Advisor Group left its Ironwood Pharmaceuticals share count unchanged in Q4 2019.
Ironwood Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4986 holding.
Advisor Group first reported a position in Ironwood Pharmaceuticals in Q3 2016 and has held it in 14 quarters since.
Advisor Group's Ironwood Pharmaceuticals position peaked at $11K in Q3 2018.
195 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.